Metro Healthcare Indonesia Tbk. vs Puradelta Lestari Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Puradelta Lestari Tbk. trades at Rp137 (market cap 6.6T, 40.24M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 2.2× Puradelta Lestari Tbk.'s market cap, and Puradelta Lestari Tbk. is more actively traded (40.24M versus 346.3K). Which is the better fit depends on your goals.
| CARE | DMAS | |
|---|---|---|
Market Cap | 14.23T | 6.6T |
Volume | 346.3K | 40.24M |
Lot | 3.46K | 402.39K |
Turnover | 147.93M | 5.52B |
Average Price | 427.18 | 137.3 |
Value | 147.93M | 5.52B |
Indicative Equilibrium Price | 428 | 137 |
Indicative Equilibrium Volume | 10 | 9.27K |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.
Read more on DMAS →